Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex

References

• EmbersonJLeesKRLydenPEffect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsLancet201438499581929193525106063
   PubMed Web of Science ®Google Scholar
• HackeWKasteMBluhmkiEThrombolysis with alteplase 3 to 4.5 hours after acute ischemic strokeN Engl J Med2008359131317132918815396
   PubMed Web of Science ®Google Scholar
• DongMXHuQCShenPRecombinant tissue plasminogen activator induces neurological side effects independent on thrombolysis in mechanical animal models of focal cerebral infarction: a systematic review and meta-analysisPLoS One2016117e015884827387385
   PubMed Web of Science ®Google Scholar
• DongMXLiCMShenPRecombinant tissue plasminogen activator induces long-term anxiety-like behaviors via the ERK1/2-GAD1-GABA cascade in the hippocampus of a rat modelNeuropharmacology201712811928986280
   PubMed Web of Science ®Google Scholar
• PanCLiuNZhangPEGb761 ameliorates neuronal apoptosis and promotes angiogenesis in experimental intracerebral hemorrhage via RSK1/GSK3beta pathwayMol Neurobiol20185521556156728185127
   PubMed Web of Science ®Google Scholar
• MaclennanKMDarlingtonCLSmithPFThe CNS effects of Ginkgo biloba extracts and ginkgolide BProg Neurobiol200267323525712169298
   PubMed Web of Science ®Google Scholar
• SnitzBEO’MearaESCarlsonMCGinkgo biloba for preventing cognitive decline in older adults: a randomized trialJAMA2009302242663267020040554
   PubMed Web of Science ®Google Scholar
• BeekTAVGinkgolides and bilobalide: their physical, chromatographic and spectroscopic propertiesBioorg Med Chem200513175001501215993092
   PubMed Web of Science ®Google Scholar
• PrehnJHKrieglsteinJPlatelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick tel-encephalon and protect the rat hippocampus and neocortex from ischemic injury in vivoJ Neurosci Res19933421791888095559
   PubMed Web of Science ®Google Scholar
• Le BarsPLKatzMMBermanNItilTMFreedmanAMSchatzbergAFA placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study GroupJAMA199727816132713329343463
   PubMed Web of Science ®Google Scholar
• ZengXLiuMYangYLiYAsplundKGinkgo biloba for acute ischaemic strokeCochrane Database Syst Rev20054CD003691
   PubMedGoogle Scholar
• BaiSZhangXChenZInsight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxineSci Rep201771959128852120
   PubMed Web of Science ®Google Scholar
• MaSLiuXXuQZhangXTransport of ginkgolides with different lipophilicities based on an hCMEC/D3 cell monolayer as a blood-brain barrier cell modelLife Sci201411429310125139831
   PubMed Web of Science ®Google Scholar
• OberpichlerHSauerDRossbergCMennelHDKrieglsteinJPAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampusJ Cereb Blood Flow Metab19901011331352298830
   PubMed Web of Science ®Google Scholar
• LiebgottTMiollanMBerchadskyYDrieuKCulcasiMPietriSComplementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusionBasic Res Cardiol200095536837711099163
   PubMed Web of Science ®Google Scholar
• LiangZBaiSShenPGC-MS-based metabolomic study on the antidepressant-like effects of diterpene ginkgolides in mouse hippocampusBehav Brain Res201631411612427498146
   PubMed Web of Science ®Google Scholar
• GengJLAaJYFengSQExploring the neuroprotective effects of Ginkgolides injection in a rodent model of cerebral ischemia-reperfusion injury by GC-MS based metabolomic profilingJ Pharm Biomed Anal201714219028514718
   PubMed Web of Science ®Google Scholar
• KikuchiKTanakaEMuraiYTancharoenSClinical trials in acute ischemic strokeCNS Drugs2014281092993825160686
   PubMed Web of Science ®Google Scholar
• LindonJCNicholsonJKHolmesEContemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET projectToxicol Appl Pharmacol2003187313714612662897
   PubMed Web of Science ®Google Scholar
• NicholsonJKWilsonIDUnderstanding “global” systems biology: metabonomics and the continuum of metabolismNat Rev Drug Discov20032866867612904817
   PubMed Web of Science ®Google Scholar
• BaiSZhouCChengP1H NMR-based metabolic profiling reveals the effects of fluoxetine on lipid and amino acid metabolism in astrocytesInt J Mol Sci20151648490850425884334
   PubMed Web of Science ®Google Scholar
• ZhengPWangYChenLIdentification and validation of urinary metabolite biomarkers for major depressive disorderMol Cell Proteomics201312120721423111923
   PubMed Web of Science ®Google Scholar
• LiuLZhouXZhangYThe identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depressionBehav Brain Res201630514815626947756
   PubMed Web of Science ®Google Scholar
• ChenGYangDYangYAmino acid metabolic dysfunction revealed in the prefrontal cortex of a rat model of depressionBehav Brain Res201527828629224861712
   PubMed Web of Science ®Google Scholar
• GläscherJAdolphsRDamasioHLesion mapping of cognitive control and value-based decision making in the prefrontal cortexProc Natl Acad Sci U S A201210936146811468622908286
   PubMed Web of Science ®Google Scholar
• WardenMRSelimbeyogluAMirzabekovJJA prefrontal cortex-brainstem neuronal projection that controls response to behavioural challengeNature2012492742942843223160494
   PubMed Web of Science ®Google Scholar
• BaiSHuQChenZBrain region-specific metabolite networks regulate antidepressant effects of venlafaxineRSC Adv20177734635846369
   Web of Science ®Google Scholar
• ZhengPZengBZhouCGut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolismMol Psychiatry201621678679627067014
   PubMed Web of Science ®Google Scholar
• ClarkJDGebhartGFGonderJCKeelingMEKohnDFThe 1996 guide for the care and use of laboratory animalsILAR J1997381414811528046
   PubMedGoogle Scholar
• LapergueBDangBQDesillesJPHigh-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental strokeStroke201344369970723422087
   PubMed Web of Science ®Google Scholar
• ZuoWChenJZhangSIMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activationEur J Neurosci20143912210724649933
   PubMed Web of Science ®Google Scholar
• WangYPeiDSJiHXXingSHProtective effect of a standardized Ginkgo extract (ginaton) on renal ischemia/reperfusion injury via suppressing the activation of JNK signal pathwayPhytomedicine2008151192393118929474
   PubMed Web of Science ®Google Scholar
• LiJTangGChengKPeripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depressionMol Biosyst201410112994300125182291
   PubMedGoogle Scholar
• LuedemannAStrassburgKErbanAKopkaJTagFinder for the quantitative analysis of gas chromatography–mass spectrometry (GC-MS)-based metabolite profiling experimentsBioinformatics200824573273718204057
   PubMed Web of Science ®Google Scholar
• XiaJWishartDSUsing MetaboAnalyst 3.0 for comprehensive metabolomics data analysisCurr Protoc Bioinformatics20165514 10 1114 10 91
   Google Scholar
• YepesMSandkvistMMooreEGBuggeTHStricklandDKLawrenceDATissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related proteinJ Clin Invest2003112101533154014617754
   PubMed Web of Science ®Google Scholar
• YepesMRousselBDAliCVivienDTissue-type plasminogen activator in the ischemic brain: more than a thrombolyticTrends Neurosci2009321485518963068
   PubMed Web of Science ®Google Scholar
• RothmanSMOlneyJWGlutamate and the pathophysiology of hypoxic–ischemic brain damageAnn Neurol19861921051112421636
   PubMed Web of Science ®Google Scholar
• LauATymianskiMGlutamate receptors, neurotoxicity and neurodegenerationPflügers Arch2010460252554220229265
   PubMed Web of Science ®Google Scholar
• OlneyJWNeurotoxicity of excitatory amino acidsKainic Acid As A Tool in Neurobiology197895121
   Google Scholar
• ManganoRMSchwarczRChronic infusion of endogenous excitatory amino acids into rat striatum and hippocampusBrain Res Bull198310147516130829
   PubMed Web of Science ®Google Scholar
• AlbrechtJNorenbergMDGlutamine: a Trojan horse in ammonia neurotoxicityHepatology200644478879417006913
   PubMed Web of Science ®Google Scholar
• RaoKRJayakumarANorenbergMInduction of the mitochondrial permeability transition in cultured astrocytes by glutamineNeurochem Int200343451752312742099
   PubMed Web of Science ®Google Scholar
• JayakumarARRama RaoKSchousboeANorenbergMDGlutamine-induced free radical production in cultured astrocytesGlia200446329630115048852
   PubMed Web of Science ®Google Scholar
• McQuailJAFrazierCJBizonJLMolecular aspects of age-related cognitive decline: the role of GABA signalingTrends Mol Med201521745046026070271
   PubMed Web of Science ®Google Scholar
• BradfordHGlutamate, GABA and epilepsyProg Neurobiol19954764775118787032
   PubMed Web of Science ®Google Scholar
• TaylorSFTsoIFGABA abnormalities in schizophrenia: a methodological review of in vivo studiesSchizophr Res20151671–3849025458856
   PubMed Web of Science ®Google Scholar
• McNamaraDDingledineRDual effect of glycine on NMDA-induced neurotoxicity in rat cortical culturesJ Neurosci19901012397039761980134
   PubMed Web of Science ®Google Scholar
• PatelJZinkandWCThompsonCKeithRSalamaARole of glycine in the N-methyl-d-aspartate-mediated neuronal cytotoxicityJ Neurochem19905438498542106010
   PubMed Web of Science ®Google Scholar
• CarmonaEGomesCTrolinGEffect of aminooxyacetic acid (AOAA) on GABA levels in some parts of the rat brainNaunyn Schmiedebergs Arch Pharmacol1980312151557393347
   PubMed Web of Science ®Google Scholar
• DavanzoJPGreigMECroninMAAnticonvulsant properties of amino-oxyacetic acidAm J Physiol196120183383713883717
   PubMed Web of Science ®Google Scholar
• LiG-FZhangJ-XLuoH-KEffect of aminooxyacetic acid on focal cerebral ischemia injury in ratsChin J Anesthesiol2011318984986
   Google Scholar
• DaniottiMLaMGFioriniPFilippiLNew developments in the treatment of hyperammonemia: emerging use of carglumic acidInt J Gen Med20114212821403788
   PubMedGoogle Scholar
• NedergaardMGoldmanSADesaiSPulsinelliWAAcid-induced death in neurons and gliaJ Neurosci1991118248924971869926
   PubMed Web of Science ®Google Scholar
• WeimbsTStoffelWProteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLPBiochemistry1992314912289122961281423
   PubMed Web of Science ®Google Scholar
• HsiaoGLinKHChangYProtective mechanisms of inosine in platelet activation and cerebral ischemic damageArterioscler Thromb Vasc Biol20052591998200415976325
   PubMed Web of Science ®Google Scholar
• ShenHChenG-JHarveyBKBickfordPCWangYInosine reduces ischemic brain injury in ratsStroke200536365465915692110
   PubMed Web of Science ®Google Scholar
• GomesCVKasterMPToméARAgostinhoPMCunhaRAAdenosine receptors and brain diseases: neuroprotection and neurodegenerationBiochim Biophys Acta2011180851380139921145878
   PubMed Web of Science ®Google Scholar